Proteinase-activated receptors (PARs) as targets for antiplatelet therapy.

Saved in:
Bibliographic Details
Title: Proteinase-activated receptors (PARs) as targets for antiplatelet therapy.
Authors: Cunningham M; Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, U.K. margaret.cunningham@strath.ac.uk., McIntosh K; Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, U.K., Bushell T; Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, U.K., Sloan G; Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, U.K., Plevin R; Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, U.K.
Source: Biochemical Society transactions [Biochem Soc Trans] 2016 Apr 15; Vol. 44 (2), pp. 606-12.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Portland Press On The Behalf Of The Biochemical Society Country of Publication: England NLM ID: 7506897 Publication Model: Print Cited Medium: Internet ISSN: 1470-8752 (Electronic) Linking ISSN: 03005127 NLM ISO Abbreviation: Biochem Soc Trans Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1470-8752
DOI:10.1042/BST20150282